Loading...
OTC Markets
Totals
Securities
12,234
Dollar Vol
$2.2B
Share Vol
4B
Trades
332,561

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

PETV
PetVivo Holdings Inc.

Common Stock

0.80

0.00

0.00%

0.77 / 0.80 (9200 x 1000)

Real-Time Best Bid & Ask: 05:00pm 07/25/2025
Delayed (15 Min) Trade Data: 03:48pm 07/25/2025

0.793

0.755 - 0.80

12,249

Market Cap calculated only for this class of securities.

19,577,110

Real-Time Level 2 Quote
Bid
Ask
MPID
MPID
Bid Price
Bid Price
Size
Size
Time
Time
Citadel Securities
CDEL
0.778,00015:02
GTS Securities LLC
GTSM
0.771,20015:02
G1 Execution Services, LLC
ETRF
0.767,00014:24
CANACCORD GENUITY LLC.
CSTI
0.761,00014:41
Puma Capital, LLC
PUMA
0.7551,00008:10
MPID
MPID
Ask Price
Ask Price
Size
Size
Time
Time
GTS Securities LLC
GTSM
0.801,00014:48
Puma Capital, LLC
PUMA
0.8451,00008:10
G1 Execution Services, LLC
ETRF
0.89561,00014:22
CANACCORD GENUITY LLC.
CSTI
0.89561,00015:48
Maxim Group LLC
MAXM
0.94811,00011:21
More
Trade Data
Date
Date
Timestamp
Timestamp
Price
Price
$ Change
$ Change
Volume
Volume
07/25/202515:48:06
0.80
0.00500
07/25/202515:02:50
0.80
0.01200
07/25/202514:48:51
0.79
0.002,000
07/25/202514:22:35
0.79
0.04200
07/25/202512:24:07
0.755
-0.042,000
More Irregular/odd lot trades, which are not considered for the Open, High, Low or Closing prices, are not shown in trade data table.
Filings and Disclosure
Company Description
Petvivo Holdings, Inc. and its wholly-owned subsidiary Petvivo Animal Health, Inc. (collectively "Petvivo"), is based in Edina, Minnesota. It is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices and therapeutics for equine and companion animals. PetVivo believes that it can leverage the investments in the human bio-materials and medical device industries to commercialize medical devices and therapeutics to animals in a capital and time efficient way. PetVivo's strategy is to internally develop and/or in-license proprietary products from human medical device companies specifically for use in pets. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than the more stringently regulated pharmaceuticals.
Videos
Bloomberg Visionaries Show Featuring PetVivo Holdings Inc.
More
OTCQB Venture Market Logo
Joined OTCQB 07/2024
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Securities
Other PetVivo Holdings Inc. Securities
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.